IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0199575.html
   My bibliography  Save this article

Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis

Author

Listed:
  • Xavier Armoiry
  • Alexander Tsertsvadze
  • Martin Connock
  • Pamela Royle
  • G J Melendez-Torres
  • Pierre-Jean Souquet
  • Aileen Clarke

Abstract

Purpose: This systematic review with network meta-analysis compared the efficacy and safety of currently licensed second-line treatments in patients with late stage non-small cell lung cancer (NSCLC). Methods: Randomised controlled trials (RCTs) of participants with advanced/metastatic NSCLC receiving second/third line treatments were screened. We searched electronic databases (MEDLINE; EMBASE; Web of Science) from January, 2000 to July, 2017. Findings: We included 11 RCTs (7,581 participants) comparing nine drugs. All drugs except for erlotinib significantly improved OS compared to docetaxel. Nivolumab was the highest ranking drug followed by atezolizumab and pembrolizumab. There was no significant difference in OS across these three drugs (HR = 0.98, 95% CI 0.79, 1.21 for nivolumab vs atezolizumab; HR = 0.98, 95% CI 0.77, 1.25 for nivolumab vs pembrolizumab). For PFS, ramucirumab + docetaxel and nivolumab were the drugs with the highest ranking. All interventions except ramucirumab + docetaxel had a reduced risk for severe drug-related AEs vs. docetaxel. Of the drugs with the highest ranking on AEs, nivolumab was significantly safer compared to atezolizumab (RR = 0.55, 95% CI 0.38, 0.79) or pembrolizumab (RR = 0.52, 95% CI 0.34, 0.81). Implications: Nivolumab, pembrolizumab and atezolizumab exhibited superior benefit/risk balance compared to other licensed drugs used late stage NSCLC. Our results indicate that the use of immunotherapies in people diagnosed with non-specific late stage NSCLC should be promoted. The use of docetaxel may now be judged irrelevant as a comparator intervention for approval of new drugs for second line treatment of NSCLC. Study registration number: PROSPERO CRD42017065928.

Suggested Citation

  • Xavier Armoiry & Alexander Tsertsvadze & Martin Connock & Pamela Royle & G J Melendez-Torres & Pierre-Jean Souquet & Aileen Clarke, 2018. "Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis," PLOS ONE, Public Library of Science, vol. 13(7), pages 1-18, July.
    • Handle: RePEc:plo:pone00:0199575
    DOI: 10.1371/journal.pone.0199575
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199575
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199575&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0199575?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Georgia Salanti & Cinzia Del Giovane & Anna Chaimani & Deborah M Caldwell & Julian P T Higgins, 2014. "Evaluating the Quality of Evidence from a Network Meta-Analysis," PLOS ONE, Public Library of Science, vol. 9(7), pages 1-14, July.
    2. Anna Chaimani & Julian P T Higgins & Dimitris Mavridis & Panagiota Spyridonos & Georgia Salanti, 2013. "Graphical Tools for Network Meta-Analysis in STATA," PLOS ONE, Public Library of Science, vol. 8(10), pages 1-12, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Cho-Hao Lee & Po-Huang Chen & Chin Lin & Chieh-Yung Wang & Ching-Liang Ho, 2020. "A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia," PLOS ONE, Public Library of Science, vol. 15(1), pages 1-18, January.
    2. Cho Naing & Maxine A Whittaker & Norah Htet Htet & Saint Nway Aye & Joon Wah Mak, 2019. "Efficacy of antimalarial drugs for treatment of uncomplicated falciparum malaria in Asian region: A network meta-analysis," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-16, December.
    3. Fernanda S Tonin & Helena H Borba & Antonio M Mendes & Astrid Wiens & Fernando Fernandez-Llimos & Roberto Pontarolo, 2019. "Description of network meta-analysis geometry: A metrics design study," PLOS ONE, Public Library of Science, vol. 14(2), pages 1-14, February.
    4. Shannon M Sullivan & Doug Coyle & George Wells, 2014. "What Guidance Are Researchers Given on How to Present Network Meta-Analyses to End-Users such as Policymakers and Clinicians? A Systematic Review," PLOS ONE, Public Library of Science, vol. 9(12), pages 1-18, December.
    5. Konstantinos Katsanos & Panagiotis Kitrou & Stavros Spiliopoulos & Ioannis Maroulis & Theodore Petsas & Dimitris Karnabatidis, 2017. "Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A net," PLOS ONE, Public Library of Science, vol. 12(9), pages 1-31, September.
    6. Dandan Li & Tiansheng Wang & Su Shen & Sheng Cheng & Junxian Yu & Yang Zhang & Chao Zhang & Huilin Tang, 2015. "Effects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-Analysis," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-14, December.
    7. Dong Hyuk Kang & Kang Su Cho & Won Sik Ham & Hyungmin Lee & Jong Kyou Kwon & Young Deuk Choi & Joo Yong Lee, 2016. "Comparison of High, Intermediate, and Low Frequency Shock Wave Lithotripsy for Urinary Tract Stone Disease: Systematic Review and Network Meta-Analysis," PLOS ONE, Public Library of Science, vol. 11(7), pages 1-22, July.
    8. Chao Zhang & Jiancheng Guan, 2017. "How to identify metaknowledge trends and features in a certain research field? Evidences from innovation and entrepreneurial ecosystem," Scientometrics, Springer;Akadémiai Kiadó, vol. 113(2), pages 1177-1197, November.
    9. Michael C Sulz & Arne Kröger & Meher Prakash & Christine N Manser & Henriette Heinrich & Benjamin Misselwitz, 2016. "Meta-Analysis of the Effect of Bowel Preparation on Adenoma Detection: Early Adenomas Affected Stronger than Advanced Adenomas," PLOS ONE, Public Library of Science, vol. 11(6), pages 1-17, June.
    10. Ivan D Florez & Areti-Angeliki Veroniki & Reem Al Khalifah & Juan J Yepes-Nuñez & Javier M Sierra & Robin W M Vernooij & Jorge Acosta-Reyes & Claudia M Granados & Giordano Pérez-Gaxiola & Carlos Cuell, 2018. "Comparative effectiveness and safety of interventions for acute diarrhea and gastroenteritis in children: A systematic review and network meta-analysis," PLOS ONE, Public Library of Science, vol. 13(12), pages 1-22, December.
    11. Jintae Park & Sungha Yoon & Chaeyoung Lee & Junseok Kim, 2020. "A Simple Method for Network Visualization," Mathematics, MDPI, vol. 8(6), pages 1-13, June.
    12. Young Sung Kim & Jihyun Song & Byung Gun Lim & Il Ok Lee & Young Ju Won, 2020. "Different classes of videoscopes and direct laryngoscopes for double-lumen tube intubation in thoracic surgery: A systematic review and network meta-analysis," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-18, August.
    13. Yue-Mei Jin & Shan-Shan Liu & Jun Chen & Yan-Nan Chen & Chen-Chen Ren, 2018. "Robotic radical hysterectomy is superior to laparoscopic radical hysterectomy and open radical hysterectomy in the treatment of cervical cancer," PLOS ONE, Public Library of Science, vol. 13(3), pages 1-14, March.
    14. Navkaranbir S Bajaj & Rajat Kalra & Nirav Patel & Taimoor Hashim & Hemant Godara & Sameer Ather & Garima Arora & Tilak Pasala & Thomas T Whitfield & David C McGiffin & Mustafa I Ahmed & Steven G Lloyd, 2016. "Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-14, October.
    15. Tamara Kerber Tedesco & Thais Gimenez & Isabela Floriano & Anelise Fernandes Montagner & Lucila Basto Camargo & Ana Flávia Bissoto Calvo & Susana Morimoto & Daniela Prócida Raggio, 2018. "Scientific evidence for the management of dentin caries lesions in pediatric dentistry: A systematic review and network meta-analysis," PLOS ONE, Public Library of Science, vol. 13(11), pages 1-20, November.
    16. Byung-Ho Yoon & Tae-young Kim & Young Seung Ko & Young-Kyun Lee & Yong-Chan Ha & Kyung-Hoi Koo, 2018. "Optimal use of tranexamic acid for total hip arthroplasty: A network meta-analysis," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-17, October.
    17. Nadera Ahmadzai & Wei Cheng & Shaun Kilty & Leila Esmaeilisaraji & Dianna Wolfe & James Bonaparte & David Schramm & Elizabeth Fitzpatrick & Vincent Lin & Becky Skidmore & Brian Hutton, 2020. "Pharmacologic and surgical therapies for patients with Meniere’s disease: A systematic review and network meta-analysis," PLOS ONE, Public Library of Science, vol. 15(9), pages 1-28, September.
    18. Stefanie Reken & Sibylle Sturtz & Corinna Kiefer & Yvonne-Beatrice Böhler & Beate Wieseler, 2016. "Assumptions of Mixed Treatment Comparisons in Health Technology Assessments - Challenges and Possible Steps for Practical Application," PLOS ONE, Public Library of Science, vol. 11(8), pages 1-16, August.
    19. Chunhu Shi & Jo C Dumville & Nicky Cullum, 2018. "Support surfaces for pressure ulcer prevention: A network meta-analysis," PLOS ONE, Public Library of Science, vol. 13(2), pages 1-29, February.
    20. Keith Tolley & Michael Hutchinson & Xiaojun You & Ping Wang & Bjoern Sperling & Ankush Taneja & Mohammed Kashif Siddiqui & Elizabeth Kinter, 2015. "A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-21, June.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0199575. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.